NeuroBo Pharmaceuticals Announces the Closing of up to $70 Million Concurrent Private Placement and Registered Direct Offering Priced At-the-Market Under Nasdaq Rules ...Middle East

$20 million upfront with up to an additional $50 million of aggregate gross proceeds upon the exercise in full of clinical milestone-linked Series Warrants are expected to provide cash runway to complete the Phase 1 Part 3 clinical trial CAMBRIDGE, Mass., June 25, 2024 /PRNewswire/ --...

Hence then, the article about neurobo pharmaceuticals announces the closing of up to 70 million concurrent private placement and registered direct offering priced at the market under nasdaq rules was published today ( Wednesday 26/06/2024 - 12:09 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( NeuroBo Pharmaceuticals Announces the Closing of up to $70 Million Concurrent Private Placement and Registered Direct Offering Priced At-the-Market Under Nasdaq Rules )

Also on site :

• Brandon Sanderson’s Literary Fantasy Universe ‘Cosmere’ Picked Up by Apple TV (Exclusive)
• Merz rejects Zelensky’s ‘concrete date’ for EU membership
• Driver ‘intentionally’ rams car into synagogue in New York (VIDEO)